Twist Bioscience Corp vs Wipro Limited — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while Wipro Limited trades at $1.87 (market cap $18.49B). The key difference: Wipro Limited is far larger — about 3.4× Twist Bioscience Corp's market cap, and Wipro Limited pays a 4.68% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TWST | WIT | |
|---|---|---|
Market Cap | $5.45B | $18.49B |
Sector | Health | Technology |
52-Week High | $102.88 | $3.06 |
52-Week Low | $24.16 | $1.82 |
Enterprise Value | $5.37B | $16.42B |
Dividend Yield | — | 4.68% |
Trailing returns across standard periods
Latest headlines on both assets
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →